C-reactive protein predicts death in patients with previous premature myocardial infarction - A 10 year follow-up study

被引:81
作者
Retterstol, L
Eikvar, L
Bohn, M
Bakken, A
Erikssen, J
Berg, K
机构
[1] Univ Oslo, Inst Med Genet, N-0315 Oslo, Norway
[2] Univ Oslo, Ulleval Hosp, Dept Med Genet, Oslo, Norway
[3] Univ Oslo, Ulleval Hosp, Dept Clin Chem, Oslo, Norway
[4] Cent Hosp Akershus, Dept Med, Akershus, Norway
关键词
C-reactive protein; prognosis; myocardial infarction; follow-up studies;
D O I
10.1016/S0021-9150(01)00595-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Atherosclerosis is an inflammatory disease. C-reactive protein (CRP), a marker of inflammation. is associated with coronary heart disease (CHD). We measured CRP in a cohort of 347 patients (193 males and 54 females) who had had their first myocardial infarction (MI) at age less than or equal to 55 (males) or less than or equal to 60 (females). The cut-off values of the 25th, 50th and 75th centiles of CRP were 1.20, 2.37 and 4.30 mg/l. After 10 years, a total of 44 patients (17.8%) had died, 36 (81.8%) of cardiac causes. Unadjusted and adjusted (i.e. for age, ejection fraction (EF), serum total cholesterol (TC), fibrinogen, smoking and hypertension) relative risks (RRs) for total and cardiac mortality were generated. CRP was a strong predictor of death of all causes due to its strength as predictor of cardiac death. The RR of cardiac death was doubled with increasing CRP quartiles, and patients in the top quartile had six times as high risk of cardiac death as patients in the lowest quartile. The RRs were moderately attenuated after adjustment. but still significant. We conclude that CRP is a strong predictor of mortality in patients with premature MI. Thus, inflammation appears to be a critical prognostic factor in patients with previous premature MI. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:433 / 440
页数:8
相关论文
共 30 条
[1]   THE ACUTE-PHASE RESPONSE [J].
BAUMANN, H ;
GAULDIE, J .
IMMUNOLOGY TODAY, 1994, 15 (02) :74-80
[2]  
BERG K, 1989, CLIN GENET, V36, P229
[3]  
BOHN M, 1993, CLIN GENET, V44, P292
[4]  
CLAUSS A., 1957, ACTA HAEMATOL, V17, P237
[5]   Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses [J].
Danesh, J ;
Whincup, P ;
Walker, M ;
Lennon, L ;
Thomson, A ;
Appleby, P ;
Gallimore, JR ;
Pepys, MB .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7255) :199-204
[6]  
Eda S, 1998, J CLIN LAB ANAL, V12, P137, DOI 10.1002/(SICI)1098-2825(1998)12:3<137::AID-JCLA2>3.0.CO
[7]  
2-6
[8]   FIBRINOGEN AS A CARDIOVASCULAR RISK FACTOR - A METAANALYSIS AND REVIEW OF THE LITERATURE [J].
ERNST, E ;
RESCH, KL .
ANNALS OF INTERNAL MEDICINE, 1993, 118 (12) :956-963
[9]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[10]  
Haverkate F, 1997, LANCET, V349, P462, DOI 10.1016/S0140-6736(96)07591-5